Back to Journals » OncoTargets and Therapy » Volume 9

Low-grade nasopharyngeal papillary adenocarcinoma: a case report and review of the literature

Authors Wang X, Yan H, Luo Y, Fan T

Received 12 November 2015

Accepted for publication 9 March 2016

Published 18 May 2016 Volume 2016:9 Pages 2955—2959

DOI https://doi.org/10.2147/OTT.S100447

Checked for plagiarism Yes

Review by Single-blind

Peer reviewers approved by Dr Colin Mak

Peer reviewer comments 3

Editor who approved publication: Professor Min Li


Xiaoli Wang,1,2 Hongjiang Yan,1 Yijun Luo,1,2 Tingyong Fan1

1Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Jinan, 2School of Medicine and Life Sciences, Shandong Academy of Medical Sciences, University of Jinan, Jinan, People’s Republic of China

Abstract: Low-grade nasopharyngeal papillary adenocarcinoma is an extremely rare tumor, with only a limited number of cases reported in the literature. Some published studies have paid more attention to the clinicopathological features of nasopharyngeal adenocarcinoma, while little effort has been made to study the optimal therapeutic strategies. We report about a woman diagnosed with low-grade nasopharyngeal papillary adenocarcinoma. She received the treatment approach that combined transnasal endoscopic surgery to remove the lesion with postoperative radiotherapy for nasal cavity. There was no evidence of recurrence after 4 months of surgery, and further follow-up is being continued. Through this example, we wanted to explore the optimal therapeutic strategies for primary nasopharyngeal adenocarcinomas.

Keywords: nasopharyngeal adenocarcinoma, immunohistochemistry, treatment policy, survival and prognosis
 

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]